Newron reports exceptional one-year results of study 014/15

EQS-News: Newron Pharmaceuticals S.p.A.


/ Key word: Study results





Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia...

Related Keywords

United Kingdom , United Arab Emirates , Italy , Bresso , Lombardia , Seika , Kyongsang Bukto , South Korea , United States , Japan , Switzerland , Canada , Hempstead , Gloucestershire , Israel , Milan , Australia , India , Sri Lanka , Germany , America , Ravi Anand , Valentin Handschin , Stefan Weber , Paul Sagan , John Kane , Anne Hennecke Caroline Bergmann , Newron Pharmaceuticals , Mc Services , Supernus Pharmaceuticals , European Union , Barbara Zucker School Of Medicine , Negative Syndrome Scale , Clinical Global Impression , Strauss Carpenter Level , Chief Medical Officer , Professor John Kane , Barbara Zucker School , Hempstead New York , Latin America , Meiji Seika , Ciara Martin , Natalie Garland Collins , Caroline Bergmann , Markets ,